TREA

87826220 - DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE

Follow

Information

  • Trademark
  • 87826220
  • Serial Number
    87826220
  • Filing Date
    March 08, 2018
    6 years ago
  • Transaction Date
    May 20, 2019
    5 years ago
  • Status Date
    May 20, 2019
    5 years ago
  • Published for Opposition Date
    August 21, 2018
    6 years ago
  • Location Date
    October 16, 2018
    6 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BEDNARZ, DUSTIN THOMAS
  • Attorney Name
    Eric Kelly
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007%" AND "OCULAR SCIENCE"
  • DM0000: The mark consists of the words "Dexamethasone PO4 / Moxifloxacin HCl / Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" above the words of "OMNI by OCULAR SCIENCE". The "Dexamethasone PO4 /" words are above the "Moxifloxacin HCl / Bromfenac" words. The "Moxifloxacin HCl / Bromfenac" words are above the "Sodium Sesquihydrate" words. The "Sodium Sesquihydrate" words are above the "0.1% / 0.5% / 0.007%" words. The "Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
  • GS0051: Ophthalmic preparations
  • PM0001: DEXAMETHASONE PHOSPHATE / MOXIFLOXACIN HYDROCHLORIC ACID/ BROMFENAC SODIUM SESQUIHYDRATE ONE TENTH PERCENT / 5 TENTHS PERCENT / 7 THOUSANDTHS PERCENT OMNI BY OCULAR SCIENCE
Case File Event Statements
  • 5/20/2019 - 5 years ago
    16 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 5/20/2019 - 5 years ago
    15 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 10/16/2018 - 6 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/21/2018 - 6 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/21/2018 - 6 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/1/2018 - 6 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/16/2018 - 6 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 7/2/2018 - 6 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/27/2018 - 6 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/27/2018 - 6 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/27/2018 - 6 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/27/2018 - 6 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/20/2018 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/15/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/12/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP